Riccardo Lacchini

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Angiotensin Converting Enzyme

Top Venues

Antioxidants (Basel, Switzerland)

Pharmacogenomics

Healthcare (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mila S Cunha, Riccardo Lacchini, José Eduardo Tanus-Santos
Facilitating Nitrite-Derived S-Nitrosothiol Formation in the Upper Gastrointestinal Tract in the Therapy of Cardiovascular Diseases. Antioxidants (Basel, Switzerland) 13 (6) (2024)
Mila S Cunha, Riccardo Lacchini, José Eduardo Tanus-Santos
Facilitating Nitrite-Derived S-Nitrosothiol Formation in the Upper Gastrointestinal Tract in the Therapy of Cardiovascular Diseases. Antioxidants (Basel, Switzerland) 13 (6) (2024)
Edilaine Cristina da Silva Gherardi-Donato, Larissa Bessani Hidalgo Gimenez, Maria Neyrian de Fátima Fernandes, Riccardo Lacchini, Elton Brás Camargo-Júnior, Kranya Victoria Diaz-Serrano, Melissa De Oliveira Melchior, Raquel García Pérez, Jorge Riquelme, Emilene Reisdorfer
Mindfulness Practice Reduces Hair Cortisol, Anxiety and Perceived Stress in University Workers: Randomized Clinical Trial. Healthcare (Basel, Switzerland) 11 (21) (2023)
Warlley Rosa Cunha, Isabella Campos Gaspar, Beatriz Cazarim de Souza, Bárbara Dias Lana Martins, Josiane Aparecida de Miranda, Carla Márcia Moreira Lanna, José Eduardo Tanus-Santos, Riccardo Lacchini, Vanessa A Belo
High molecular weight adiponectin as a biomarker of hypertension in children and adolescents with obesity. European journal of pediatrics (2023)
Leticia Perticarrara Ferezin, Cezar Kayzuka Cotta Filho, Vitória Carolina Rondon Pereira, Murilo Ferreira de Andrade, Carlos Augusto Fernandes Molina, Silvio Tucci, José Eduardo Tanus-Santos, Riccardo Lacchini
The rs2682826 Polymorphism of the NOS1 Gene Is Associated with the Degree of Disability of Erectile Dysfunction. Life (Basel, Switzerland) 13 (5) (2023)
Aline Esposito, Cezar Kayzuka Cotta Filho, Riccardo Lacchini
Beyond eNOS: Genetic influence in NO pathway affecting drug response. Genetics and molecular biology 45 (3 Suppl 1) (2022)
Itiana Castro Menezes, Cristiane von Werne Baes, Fernanda Viana Fígaro-Drumond, Brisa Burgos Dias Macedo, Ana Carolina Bueno, Riccardo Lacchini, Marcelo Feijó de Mello, Margaret de Castro, Mário Francisco Juruena
Differential Diagnosis of Major Depressive Disorder and Bipolar Disorder: Genetic and Hormonal Assessment and the Influence of Early-Life Stress. Brain sciences 12 (11) (2022)
Gustavo H Oliveira-Paula, Fernanda Borchers Coeli-Lacchini, Letícia Perticarrara Ferezin, Graziele C Ferreira, Lucas C Pinheiro, Waynice N Paula-Garcia, Luis V Garcia, Jose E Tanus-Santos, Riccardo Lacchini
Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability. European journal of clinical pharmacology 77 (6) (2021)
Sherliane Carla Pereira, Cezar Kayzuka Cotta Filho, Riccardo Lacchini
The need for further studies examining the role of endothelial nitric oxide synthase polymorphisms in drug response. Pharmacogenomics 22 (7) (2021)
Daniela Alves Pereira, Valéria Cristina Sandrim, Ana C Palei, Lorena M Amaral, Vanessa A Belo, Riccardo Lacchini, Ricardo C Cavalli, Jose E Tanus-Santos, Marcelo Rizzatti Luizon
NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia. Pharmacogenomics 22 (8) (2021)
Valéria Cristina Sandrim, Marcelo Rizzatti Luizon, Eliane Pilan, Mayara Caldeira-Dias, Fernanda Borchers Coeli-Lacchini, Georgia Kors, Iuly Berndt, Riccardo Lacchini, Ricardo de Carvalho Cavalli
Interaction Between NOS3 and HMOX1 on Antihypertensive Drug Responsiveness in Preeclampsia. Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 42 (8) (2020)
Gustavo H Oliveira-Paula, Sherliane Carla Pereira, Jose E Tanus-Santos, Riccardo Lacchini
Pharmacogenomics And Hypertension: Current Insights. Pharmacogenomics and personalized medicine 12 (2019)